EUVIMEDEUVIMED entdecken
Crossref

Alzheimer’s: How Emerging Gene Editing Strategies Could Transform Treatment

Harshith Potluri

Journal of Youth Impact · 10.04.2026

DOI: 10.66245/jyi.v1.i2.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Youth Impact, online erschienen am 10.04.2026. Verfasst von Harshith Potluri.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite decades of research and testing, Alzheimer’s disease remains a progressive and currently terminal neurodegenerative disorder which affects over 55 million people across the world. It is a leading cause of mortality among the elderly without a full cure. Treatments for Alzheimer’s primarily try to temporarily reduce amyloid-beta and tau accumulation in the brain, with these types of treatments being temporary. The effects of Alzheimer’s, including neuroinflammation, memory loss, and metabolic stress, renders Alzheimer's disease one of the most prevalent neurodegenerative conditions to date. This paper aims to find theoretical methods and solutions to improve Alzheimer’s treatment. Biomarkers, such as p-tau217, p-tau181, A-beta42/40 ratios, and neurofilament can also be used for early Alzheimer’s detection. These biomarkers can enable earlier and more accurate detection of this disease, giving us the opportunity for earlier therapeutic intervention and treatment of Alzheimer’s in patients. Gene editing technologies have emerged as promising strategies to modify amyloid-beta and tau production to alleviate Alzheimer’s. While CRISPR-Cas9 has seen success in reducing amyloid and tau production, several underused genetic tools, such as TALENs, Zinc Finger Nucleases, base and prime editors, and the newly developed seekRNA, offer unique advantages in precision or large scale DNA modification when dealing with mutations and diseases, especially with Alzheimer’s. However, challenges such as side effects, size, and the blood brain barrier are still formidable obstacles; continued innovation in delivery systems, including engineered AAV capsids, lipid nanoparticles, and focused ultrasound, has the possibility to enable safe and effective deployment of these tools inside of the brain and central nervous system. Together, with a combination of these methods, these strategies offer a theoretical framework for future Alzheimer’s modifying therapies that may one day move beyond symptom management.

Zitieren

APA

Potluri, H. (2026). Alzheimer’s: How Emerging Gene Editing Strategies Could Transform Treatment. Journal of Youth Impact. https://doi.org/10.66245/jyi.v1.i2.001

Vancouver

Potluri H. Alzheimer’s: How Emerging Gene Editing Strategies Could Transform Treatment. Journal of Youth Impact. 2026. doi:10.66245/jyi.v1.i2.001

BibTeX
@article{Potluri2026,
  author = {Potluri, Harshith},
  title = {Alzheimer’s: How Emerging Gene Editing Strategies Could Transform Treatment},
  journal = {Journal of Youth Impact},
  year = {2026},
  doi = {10.66245/jyi.v1.i2.001}
}
Kostenlos starten →